8-K: Universal Health Services Boosts 2025 Forecast, Expands Buyback

Universal Health Services, Inc. announced strong third-quarter 2025 financial results, raising its full-year operating forecast and increasing its stock repurchase program authorization by $1.5 billion.

Summary

• Reported net income attributable to UHS was $373.0 million, or $5.86 per diluted share, during the third quarter of 2025, compared to $258.7 million, or $3.80 per diluted share, in Q3 2024.
• Net revenues increased by 13.4% to $4.495 billion during the third quarter of 2025, compared to $3.963 billion in Q3 2024.
• Adjusted net income attributable to UHS was $362.3 million, or $5.69 per diluted share, in Q3 2025, compared to $252.5 million, or $3.71 per diluted share, in Q3 2024.
• Adjusted EBITDA net of NCI was $670.6 million during the third quarter of 2025, compared to $526.5 million in Q3 2024.
• For the first nine months of 2025, reported net income attributable to UHS was $1.043 billion, or $16.07 per diluted share, compared to $809.7 million, or $11.88 per diluted share, in the comparable period of 2024.
• Net revenues for the first nine months of 2025 increased by 9.9% to $12.879 billion, compared to $11.714 billion in the comparable period of 2024.
• Net cash provided by operating activities was $1.290 billion during the first nine months of 2025, a decrease of $119 million from $1.409 billion in the comparable period of 2024.
• The Board of Directors authorized a $1.5 billion increase to the stock repurchase program, bringing the total available authorization to $1.759 billion.
• The company repurchased 1.315 million shares for approximately $234.3 million (average $178/share) in Q3 2025, and 3.190 million shares for approximately $565.8 million (average $177/share) in the first nine months of 2025.
• The 2025 full-year operating results forecast was increased, with the midpoint of revised net revenues at $17.375 billion, Adjusted EBITDA net of NCI at $2.594 billion, and Adjusted EPS-diluted at $21.80 per share.
• Third quarter 2025 results included $90 million of pre-tax reimbursements from a D.C. Medicaid program and a $35 million pre-tax charge for increased self-insured professional and general liabilities.

Sentiment

Score: 8

Explanation: The company reported strong financial performance for Q3 and YTD 2025, significantly increased its full-year 2025 forecast, and expanded its stock repurchase program, indicating robust operational health and a commitment to shareholder returns despite some operational challenges like increased self-insurance liabilities and a decrease in operating cash flow.

Positives

• Reported net income attributable to UHS increased by 44.2% in Q3 2025 and 28.8% in YTD 2025 compared to the prior year periods.
• Net revenues grew by 13.4% in Q3 2025 and 9.9% in YTD 2025, demonstrating strong top-line performance.
• Adjusted EBITDA net of NCI increased by 27.4% in Q3 2025 and 17.2% in YTD 2025, indicating improved operational efficiency.
• The company increased its 2025 full-year operating results forecast for net revenues, Adjusted EBITDA, and Adjusted EPS-diluted, reflecting positive outlook and performance.
• The midpoint of the revised 2025 forecasted Adjusted EPS-diluted represents a 6.4% increase over the midpoint of the previous forecast.
• Acute Care Services on a same-facility basis showed strong growth in Q3 2025, with net revenues up 12.8%, adjusted admissions up 2.0%, and net revenue per adjusted admission up 9.8%.
• Behavioral Health Care Services on a same-facility basis also performed well in Q3 2025, with net revenues up 9.3%, adjusted admissions up 0.5%, and net revenue per adjusted admission up 8.8%.
• The Board of Directors authorized a $1.5 billion increase to the stock repurchase program, signaling confidence in the company's valuation and a commitment to shareholder returns.
• The company received $90 million in pre-tax reimbursements from a new Medicaid state directed payment program in Washington, D.C.

Negatives

• Net cash provided by operating activities decreased by $119 million, from $1.409 billion in the first nine months of 2024 to $1.290 billion in the first nine months of 2025, primarily due to an unfavorable change in accounts receivable and increased payments for self-insurance claims.
• A $35 million pre-tax charge was incurred in Q3 2025 to increase reserves for self-insured professional and general liabilities due to unfavorable claims trends.
• Acute care occupancy rates (licensed and available beds) slightly decreased in Q3 2025 compared to Q3 2024.
• Behavioral health adjusted admissions decreased by 0.2% on a same-facility basis for the nine-month period ended September 30, 2025.

Risks

• A significant portion of revenues are derived from federal and state government programs (Medicare and Medicaid), which are subject to statutory and regulatory changes, administrative rulings, and funding restrictions that could materially affect payments.
• Failure to renew supplemental Medicaid payment programs, failure of public hospitals to provide necessary Inter-Governmental Transfers, or failure of UHS hospitals to qualify for future funds could materially impact operating results.
• Legislation adopted on July 4, 2025, attaching work and community service requirements to Medicaid eligibility, may limit Medicaid enrollment and expenditures, reduce revenues, and increase uncompensated care.
• Potential unfavorable effects from federal government shutdowns or related negotiated agreements could impact future results of operations and financial condition.
• Increased interest rates have significantly raised interest expense, reducing free cash flow, and future significant increases could materially impact results and access to capital markets.
• Changes in laws or policies governing foreign trade, including increased trade restrictions, tariffs, or taxes on imports, could impact competitive position, business operations, and financial results.
• The outcome of known and unknown litigation, liabilities, and other claims, including matters related to Cumberland Hospital for Children and Adolescents and a verdict in Washoe County, Nevada, could have a material adverse effect on the company.

Future Outlook

The company increased its 2025 full-year operating results forecast for consolidated net revenues, Adjusted EBITDA net of NCI, and Adjusted EPS-diluted, citing strong operating trends and the recent approval of a new Medicaid supplemental payment program in Washington, D.C. The midpoint of the revised forecast represents an increase of 1.0% for net revenues, 3.9% for Adjusted EBITDA net of NCI, and 6.4% for Adjusted EPS-diluted compared to the previous forecast. The forecast excludes certain nonrecurring or non-operational items and is subject to various risk factors.

Industry Context

The healthcare industry continues to experience demand for both acute care and behavioral health services, as evidenced by Universal Health Services' growth in patient days and admissions. Government programs like Medicare and Medicaid remain critical revenue streams, but also introduce regulatory and funding uncertainties, as highlighted by the new D.C. Medicaid program and the risks associated with recent legislation. The increase in self-insured liabilities could reflect broader industry trends in claims or specific company experience, while the company's strategic focus on building or acquiring high-quality hospitals in growing markets aligns with industry expansion trends.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or global benchmarks to assess the results against industry standards.

Legal Proceedings

• Ongoing litigation and claims asserted against the company and/or its subsidiaries, including matters related to Cumberland Hospital for Children and Adolescents.
• A verdict in Washoe County, Nevada, against certain subsidiaries, the final resolution of which could have a material adverse effect on the company.

Stakeholder Impact

• Shareholders are positively impacted by strong financial performance, an increased earnings forecast, and a significant expansion of the stock repurchase program, which could lead to enhanced shareholder value.
• Employees benefit from continued operations and growth, as reflected in increased salaries, wages, and benefits expenses.
• Patients continue to receive acute care and behavioral health services, with growth in patient days and admissions indicating ongoing service provision.
• Government and regulatory bodies are impacted by the company's reliance on Medicare and Medicaid programs, including new supplemental payment programs, and are subject to potential changes from new legislation.
• Creditors may view the company's improved debt ratios (Debt/Total Capitalization, Debt/EBITDA) as a sign of stronger financial health.

Next Steps

• A conference call for investors and analysts will be held at 9:00 a.m. eastern time on October 28, 2025, with a live webcast available on the company's website.
• The company will continue to operate under the revised 2025 operating results forecast for the remainder of the year.
• Ongoing stock repurchases are expected under the expanded program as conditions allow.

Key Dates

Recommendation

Universal Health Services delivered robust Q3 and YTD 2025 financial results, demonstrating significant growth in net income and revenues across both acute and behavioral health segments. The upward revision of the full-year 2025 forecast for key metrics (net revenues, Adjusted EBITDA, and Adjusted EPS-diluted) signals strong management confidence and positive operational momentum. Furthermore, the substantial increase in the stock repurchase program authorization underscores a commitment to enhancing shareholder value. While there are noted risks related to government programs and ongoing litigation, the overall financial performance and positive outlook suggest a compelling investment opportunity.

Keywords

Healthcare, Hospital Services, Acute Care, Behavioral Health, Financial Results, Earnings, Revenue, EBITDA, Stock Repurchase, Medicaid, Medicare, UHS, Universal Health Services, Q3 2025, 2025 Forecast, Investor Relations